InvestorsHub Logo
Followers 4
Posts 862
Boards Moderated 0
Alias Born 03/06/2014

Re: caes4 post# 940

Monday, 02/01/2021 9:06:56 AM

Monday, February 01, 2021 9:06:56 AM

Post# of 1716
Here's some basic info on the SpinDx platform and what we know about Lifeloc's partnership with Sandia Corporation:

https://federallabs.org/successes/success-stories/sandia-scientist-ventures-out-to-the-public-sector-lab-on-a-disk

http://198.102.153.153/research/research_foundations/bioscience/_assets/documents/Fact_Sheets/spindx-factsheet-portable-immunoassay_20151.pdf

Sandia National Laboratories is operated and managed by National Technology and Engineering Solutions of Sandia, LLC., a wholly owned subsidiary of Honeywell International, Inc. Honeywell is a big boy and has revenue over $36 Billion/year

Sandia National Laboratories has an annual budget of $3.6 Billion

The inventors of the SpinDx platform are licensing the technology to several companies that are developing its use for point-of-care diagnostics testing, water pathogen testing, and other applications.

This is where Lifeloc comes in. They are using the SpinDx platform, in combination with the LX9 base breathalyzer platform to create a device for drug detection.

4 years ago Lifeloc acquired the exclusive rights to develop, manufacture and market Sandia's patented SpinDx™ technology for the detection of drugs of abuse.

They received the prototype almost 3 years ago and have been working to commercialize the device.

They have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in their laboratory.

Lifloc added staff in early 2020 to help with the development of the SpinDx platform.

They are attempting to introduce the marijuana breathalyzer and drug detection device by the end of this year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News